The groundbreaking treatment of the medication represents a significant development in the handling of type 2 diabetes. Distinct from existing drugs, tirzepatide impacts dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide306682.idblogmaker.com/40709210/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment